Cargando…

Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study

BACKGROUND/OBJECTIVES: Adherence is a major challenge in topical glaucoma therapy, particularly in an African context. We report a pilot study assessing adherence independently for the first time in an African context. SUBJECTS/METHODS: Participants with newly diagnosed open-angle glaucoma received...

Descripción completa

Detalles Bibliográficos
Autores principales: Murdoch, Ian, Nyakundi, David, Baker, Helen, Dulku, Simon, Kiage, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020913/
https://www.ncbi.nlm.nih.gov/pubmed/32103906
http://dx.doi.org/10.2147/PPA.S236468
_version_ 1783497833674964992
author Murdoch, Ian
Nyakundi, David
Baker, Helen
Dulku, Simon
Kiage, Daniel
author_facet Murdoch, Ian
Nyakundi, David
Baker, Helen
Dulku, Simon
Kiage, Daniel
author_sort Murdoch, Ian
collection PubMed
description BACKGROUND/OBJECTIVES: Adherence is a major challenge in topical glaucoma therapy, particularly in an African context. We report a pilot study assessing adherence independently for the first time in an African context. SUBJECTS/METHODS: Participants with newly diagnosed open-angle glaucoma received a weighed bottle of Lumigan 0.01% with counselling on therapy. The bottles were returned monthly for renewal and weighed on return to estimate drops taken during the period. Data collection was for one year with a short compliance questionnaire. RESULTS: 11 patients participated. 5 (45%) failed to complete one full year of topical therapy. The overall mean number of drops per eye per day was 1.74 (SD 0.69) for the 6 with one year of monthly returned bottles and controlled IOPs at each visit. Self-perception of compliance in these patients was good. CONCLUSION: The signs of poor adherence based on both self-report (previous literature), and in this small-scale study of an objective measure suggest medication may not be the first-line treatment of choice in this environment. Our report does, however, raise the possibility that those patients who return for repeat prescriptions and review are indeed adhering to their treatment regimens.
format Online
Article
Text
id pubmed-7020913
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-70209132020-02-26 Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study Murdoch, Ian Nyakundi, David Baker, Helen Dulku, Simon Kiage, Daniel Patient Prefer Adherence Original Research BACKGROUND/OBJECTIVES: Adherence is a major challenge in topical glaucoma therapy, particularly in an African context. We report a pilot study assessing adherence independently for the first time in an African context. SUBJECTS/METHODS: Participants with newly diagnosed open-angle glaucoma received a weighed bottle of Lumigan 0.01% with counselling on therapy. The bottles were returned monthly for renewal and weighed on return to estimate drops taken during the period. Data collection was for one year with a short compliance questionnaire. RESULTS: 11 patients participated. 5 (45%) failed to complete one full year of topical therapy. The overall mean number of drops per eye per day was 1.74 (SD 0.69) for the 6 with one year of monthly returned bottles and controlled IOPs at each visit. Self-perception of compliance in these patients was good. CONCLUSION: The signs of poor adherence based on both self-report (previous literature), and in this small-scale study of an objective measure suggest medication may not be the first-line treatment of choice in this environment. Our report does, however, raise the possibility that those patients who return for repeat prescriptions and review are indeed adhering to their treatment regimens. Dove 2020-02-10 /pmc/articles/PMC7020913/ /pubmed/32103906 http://dx.doi.org/10.2147/PPA.S236468 Text en © 2020 Murdoch et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Murdoch, Ian
Nyakundi, David
Baker, Helen
Dulku, Simon
Kiage, Daniel
Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study
title Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study
title_full Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study
title_fullStr Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study
title_full_unstemmed Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study
title_short Adherence with Medical Therapy for Primary Open-Angle Glaucoma in Kenya – A Pilot Study
title_sort adherence with medical therapy for primary open-angle glaucoma in kenya – a pilot study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020913/
https://www.ncbi.nlm.nih.gov/pubmed/32103906
http://dx.doi.org/10.2147/PPA.S236468
work_keys_str_mv AT murdochian adherencewithmedicaltherapyforprimaryopenangleglaucomainkenyaapilotstudy
AT nyakundidavid adherencewithmedicaltherapyforprimaryopenangleglaucomainkenyaapilotstudy
AT bakerhelen adherencewithmedicaltherapyforprimaryopenangleglaucomainkenyaapilotstudy
AT dulkusimon adherencewithmedicaltherapyforprimaryopenangleglaucomainkenyaapilotstudy
AT kiagedaniel adherencewithmedicaltherapyforprimaryopenangleglaucomainkenyaapilotstudy